Long-term effects of hypercalcemia in kidney transplant recipients with persistent hyperparathyroidism.
Juan Carlos Ramírez-SandovalLluvia MarinoGabriel Cojuc-KonigsbergEstefania Reul-LinaresNathalie Desire Pichardo-CabreraCristino CruzElisa Naomi Hernández-ParedesNathan Berman-ParksVanessa Vidal-RuízJonathan Mauricio Estrada-LinaresAlfredo Adolfo Reza-AlbarránRicardo Correa-RotterLuis Eduardo Morales-BuenrostroPublished in: Journal of nephrology (2023)
Long-term persistent mild hypercalcemia (tertiary hyperparathyroidism) was frequent in kidney transplant recipients in our series. This condition presented with lower phosphate and 25-hydroxyvitamin D, and higher urinary calcium and intact fibroblast growth factor 23 levels compared to kidney transplant recipients without hypercalcemia, resembling a mild form of primary hyperparathyroidism. Despite these metabolic derangements, the risk of adverse graft outcomes was low.